Kazuo Hara

Director

Aichi Cancer Center
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (35)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Intraoperative peritoneal lavage cytology (CY) influences prognosis in pancreatic cancer, and positive findings may lead to aborted surgery. Staging laparoscopy is traditionally used when no distant metastases are evident. We developed a novel method to assess CY using endoscopic ultrasound (EUS) and conducted a Phase 1 trial to evaluate its safety. This non-randomized, prospective Phase I1trial was conducted in three stages with safety monitoring after each stage. The study was approved by the institutional review board (2023–0-239) and registered (UMIN000052528). Nine patients with pancreatic ductal adenocarcinoma who were considering surgery were enrolled between September 2023 and August 2024. A 3F sheath was inserted into the upper abdomen under endoscopic and fluoroscopic guidance, followed by injection of 200 to 300 mL of saline. After postural adjustments and abdominal massage, transrectal EUS-fine-needle aspiration was used to aspirate pelvic fluid. Median age was 68 years (range, 36–80); 77.8% were male. Resectability status: resectable/borderline/unresectable (considering conversion): 4/2/3. The procedure was successful in all cases, with a median aspirated volume of 32 mL (range, 10–125). No adverse events occurred, and all patients were discharged the next day. This novel EUS-guided lavage cytology method was safe and feasible. A Phase 2 trial is planned.

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (21)

Toshio Fujisawa

Associate Professor

Juntendo University

JAPAN
View details

Hiroyuki Isayama

-

JAPAN
View details

Hironari Kato

-

JAPAN
View details

Ichiro Yasuda

Director and Professor

University of Toyama

JAPAN
View details

Shomei Ryozawa

-

JAPAN
View details

Mamoru Takenaka

Kindai University Hospital

JAPAN
View details

Yoichi Hiasa

Professor

Ehime University

JAPAN
View details

Yousuke Nakai

University of Tokyo

JAPAN
View details

Saburo Matsubara

Associate Professor

Saitama Medical University

JAPAN
View details

Itaru Naitoh

Nagoya University Graduate School of Medicine

JAPAN
View details

Masahiro Itonaga

Assistant Professor

Wakayama Medical University

JAPAN
View details

Tetsuo Takehara

Osaka University

JAPAN
View details

Yu Sunakawa

Associate Professor

St. Marianna University School of Medicine

JAPAN
View details

Yoshihide Kanno

Sendai City Medical Center

JAPAN
View details

Takao Itoi

-

JAPAN
View details

Reiko Ashida

-

JAPAN
View details

Hiroshi Kawakami

University of Miyazaki

JAPAN
View details

Akiko Todaka

Oita University

JAPAN
View details

Hirofumi Kogure

Nihon University School of Medicine

JAPAN
View details

Masayuki Kitano

Professor

Wakayama Medical University

JAPAN
View details

Atsushi Irisawa

Dokkyo Medical University

JAPAN
View details